What investment strategy does EMV Capital focus on?

EMV Capital focuses on VC, Growth strategies in the private equity space.

How many portfolio companies does EMV Capital have?

EMV Capital has 22 active portfolio companies and 1 completed exit and 1 fund tracked on GP Intel.

Where is EMV Capital headquartered?

EMV Capital is headquartered in London, United Kingdom.

What is EMV Capital's assets under management?

EMV Capital manages approximately €130M in assets under management.

What sectors does EMV Capital invest in?

EMV Capital invests across Healthcare, TMT, Industrials, Energy.

What are EMV Capital's recent exits?

Recent realized exits by EMV Capital include: OncoVerse (2017) to BTG plc.

Home/GPs/EMV Capital

DetailCard

EMV Capital

London, United Kingdom·

Venture Capital Growth Equity

·emvcapital.com

EMV Capital plc (formerly NetScientific plc) is an AIM-listed London deep-tech and life-sciences venture capital and corporate finance group. It invests directly off its balance sheet, manages the Evergreen EIS Fund and the Martlet Capital fund through the FCA-authorised EMV Capital Partners Limited, and syndicates co-investments. Total AUM was about GBP 104.7m at H1 2025 across over 70 portfolio companies.

AUM

€130M

Funds

vintages 2012

Portfolio

Exits

EMV Capital is a London venture capital firm with €130M AUM, 22 active companies and 1 exit.

SectorsHealthcare TMT Industrials Energy

Sector breakdown

23 companies

MedTech

7 · 30%

Biotech

5 · 22%

TMT

3 · 13%

HealthTech

2 · 9%

ClimateTech

1 · 4%

Software

1 · 4%

Financials

1 · 4%

AI/ML

1 · 4%

Geography breakdown

4 geographies

13 · 57%

8 · 35%

Belgium

1 · 4%

Israel

1 · 4%

Key facts

HQLondon, United Kingdom

Websiteemvcapital.com

Recent exits

EMV Capital sold OncoVerse to BTG plc in 2017 after 1 year.

Coverage notes

1 fund tracked, 23 portfolio companies (22 active · 1 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund EMV Capital has raised, with its portfolio companies. Hand-checked from public filings.

1 fund

Fund

Strategy

Vintage

Size

Assets

Exits

EMV Capital Evergreen Fund

VC2012€45M22 assets1 exits

2012 · 14yr

€45M

Unrealized

22 held

Company	Entry
AMR Bio Biotech · UK	2025
Cetromed Biotech · UK	2021
CytoVale MedTech · US	2014
DeepTech Recycling ClimateTech · UK	2022
Dname-iT Software · UK	2023
Dogtooth Technologies TMT · UK	2026
EpiBone Biotech · US	2020
FOx Biosystems MedTech · Belgium	2020
G-Tech Medical MedTech · US	2014
Glycotest MedTech · US	2012
Longevity Biotech Biotech · US	2014
Martlet Capital Financials · UK	2021
Neumitra HealthTech · US	2015
PDS Biotechnology Biotech · US	2014
PointGrab AI/ML · Israel	2021
ProAxsis MedTech · UK	2014
Q-Bot TMT · UK	2021
SageTech Medical MedTech · UK	2020
Sofant Technologies TMT · UK	2019
Ventive Industrials · UK	2022
Vortex Biotech Holdings MedTech · UK	2019
Wanda Health Healthcare · UK	2019

Realized

1 exit

Company	Entry	Exit	Type	Buyer	MOIC
OncoVerse HealthTech · US	2016	2017	Trade Sale	BTG plc	–

About EMV Capital

EMV Capital is an alternative investment platform with capital deployed across 3 active fund vehicles, headquartered in London. The firm deploys capital across European mid and small-cap businesses spanning software, TMT, healthcare and consumer.

Investment thesis

The platform combines complementary investment strategies, deploying capital across software, TMT, healthcare and consumer businesses in the United Kingdom and broader European market. Multi-strategy capital deployment enables flexibility across the business lifecycle, with the partnership culture supporting management teams through growth, transmission and selective M&A across multiple fund vintages and asset classes.

Recent activity

Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 3 fund vehicles, 49 active portfolio companies and 0 realised exits across the strategy's history.

Frequently asked questions

What investment strategy does EMV Capital focus on?: EMV Capital focuses on VC, Growth strategies in the private equity space.
How many portfolio companies does EMV Capital have?: EMV Capital has 22 active portfolio companies and 1 completed exit and 1 fund tracked on GP Intel.
Where is EMV Capital headquartered?: EMV Capital is headquartered in London, United Kingdom.
What is EMV Capital's assets under management?: EMV Capital manages approximately €130M in assets under management.
What sectors does EMV Capital invest in?: EMV Capital invests across Healthcare, TMT, Industrials, Energy.
What are EMV Capital's recent exits?: Recent realized exits by EMV Capital include: OncoVerse (2017) to BTG plc.